Novo Nordisk Aktie
47,48
EUR
-0,43
EUR
-0,89
%
46,75
EUR
-1,29
EUR
-2,68
%
Werbung
Novo Nordisk Aktie Analyse
09.09.19 | Novo Nordisk Outperform | Bernstein Research | |
05.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
02.09.19 | Novo Nordisk buy | UBS AG | |
28.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
20.08.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
12.08.19 | Novo Nordisk Outperform | Credit Suisse Group | |
09.08.19 | Novo Nordisk buy | UBS AG | |
09.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
Werbung
|
|||
09.08.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
02.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
31.07.19 | Novo Nordisk buy | UBS AG | |
08.07.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
04.07.19 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
18.06.19 | Novo Nordisk buy | UBS AG | |
17.06.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
14.06.19 | Novo Nordisk buy | Deutsche Bank AG | |
12.06.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
11.06.19 | Novo Nordisk Outperform | Credit Suisse Group | |
11.06.19 | Novo Nordisk buy | UBS AG | |
11.06.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
05.06.19 | Novo Nordisk Outperform | Bernstein Research | |
29.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
07.05.19 | Novo Nordisk buy | UBS AG | |
06.05.19 | Novo Nordisk Outperform | Credit Suisse Group | |
06.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
03.05.19 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
03.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
03.05.19 | Novo Nordisk buy | UBS AG | |
29.04.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
29.04.19 | Novo Nordisk Outperform | Credit Suisse Group | |
12.04.19 | Novo Nordisk Outperform | Bernstein Research | |
11.04.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
08.04.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
05.04.19 | Novo Nordisk buy | Deutsche Bank AG | |
20.03.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
18.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
18.03.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
05.03.19 | Novo Nordisk Outperform | Bernstein Research | |
05.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
04.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
04.02.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
04.02.19 | Novo Nordisk buy | Deutsche Bank AG | |
01.02.19 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
01.02.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
01.02.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
28.01.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
22.01.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
21.01.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
11.01.19 | Novo Nordisk buy | Deutsche Bank AG | |
03.01.19 | Novo Nordisk Outperform | Bernstein Research |
Werbung
Werbung